About us

Immunicom is one of the most promising biotech start-ups in the immunotherapy space today. We focus on creating novel immunotherapies based on our breakthrough technology platform – Immunopheresis™.

Immunopheresis is designed to address unmet medical needs in cancer, inflammatory, cardiovascular, renal and autoimmune diseases and to be accessible to broad patient populations.

With a strong talent base and financial resources, Immunicom is on an accelerated path to make its therapies widely available via partnerships with leading hospitals around the world.

Key facts

1

Immunicom’s breakthrough blood-filtering immunotherapy device works external to the body and received FDA Breakthrough Device recognition in 2018

2

With an initial focus on immuno-oncology, Immunicom has already secured CE Mark approval for use in adults with advanced, refractory, triple-negative breast cancer in Europe.

3

Immunicom R&D is working from the replicable Immunopheresis platform to create a robust pipeline of immunotherapy treatments.

4

Our clinical team is conducting multiple clinical trials around the world to potentially expand indications to address triple negative breast cancer, resistant metastatic melanoma, renal cell carcinoma and non-small cell lung cancer. Our therapy also has the potential to treat different cancers beyond those listed above.

Our Mission

To improve the quality of life for patients
in a meaningful way and expedite their
path to a healthy future.

VISION

Immunicom reimagines healing

All to often, patients face the challenging decision of sacrificing their quality of life to obtain treatment for serious, life-threatening diseases. Often choosing not to participate in care at all. We believe people should not have to make trade-offs between living fulfilling lives and healing.

We envision a future where no one needs to sacrifice living their life to the fullest in order to receive life-saving treatment.

Get in touch today

Let’s talk about what we can achieve together

Learn more about
our team